Search

Search Constraints

You searched for: Author/Creator Hliva, Valerie

Search Results

1. ACI‐24 in adults with Down syndrome: Results of a phase 1b, randomized, placebo‐controlled study. (31st December 2021)

2. ACI‐24 in adults with Down syndrome: Results of a phase 1b, randomized, placebo‐controlled study. (31st December 2021)

3. ACI‐24 vaccine in adults with Down syndrome: Human: Putative therapeutic results for Alzheimer's and related dementias. (7th December 2020)

4. Biomarker‐based development for optimized ACI‐24, a novel candidate vaccine for the treatment and prevention of Alzheimer's disease. (20th December 2022)

5. Developing a novel alpha‐synuclein positron emission tomography (PET) tracer for the diagnosis of synucleinopathies: Neuroimaging: Other neurodegenerative disorders. (7th December 2020)

6. Discovery of [18F]ACI‐12589, a Novel and Promising PET‐Tracer for Alpha‐Synuclein. (20th December 2022)

7. Initial clinical scans using [18F]ACI‐12589, a novel α‐synuclein PET‐tracer. (20th December 2022)

8. The development of [18F]ACI‐12589, a high affinity and selective alpha‐synuclein radiotracer, as a biomarker for Parkinson's disease and other synucleinopathies. (31st December 2021)